Home Drug Codes J Codes J3404 · Papzimeos
Updated July 1st, 2026

Papzimeos J Code: J3404

Injection, zopapogene imadenovec-drba suspension, per therapeutic dose

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J3404, effective October 1, 2026: $119,675.512 per HCPCS billing unit. CMS publishes none for Q3 2026. From CMS's final file.

?
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
$121,900.00
/ HCPCS billing unit · APC 0924
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
HCPCS Added Date April 1, 2026
Manufacturer Precigen, Inc
Route of Administration Subcutaneous
Generic Status Single-Source; Branded
Dosage Form Injection, Suspension

About Papzimeos

Papzimeos is a medication aligned to the HCPCS J Code: J3404 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the subcutaneous route and manufactured by Precigen, Inc.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
84768-0511-01 Papzimeos Precigen, Inc. 1 Papzimeos Subcutaneous Injection 50000… Login for More
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Papzimeos CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Papzimeos Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Recurrent Respiratory Papillomatosis (RRP)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Papzimeos billing and coding guide?
Billing and coding information for Papzimeos can be found through Precigen, Inc.. Visit Here →
Are there any available Papzimeos patient assistance programs?
Papzimeos patient assistance information can be found through Precigen, Inc.. Visit Here →
Where can I find Papzimeos prescribing information?
Papzimeos prescribing information can be found at the link below. Visit Here →
Where can I find Papzimeos side effect information?
Our team has not yet identified a source of side effects information for Papzimeos.
Does billing Papzimeos require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.